Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

TSX:VRX - Post Discussion

VALEANT PHARMACEUTICALS INTL INC > Valeant Pharma To Present At Health Care Conferences
View:
Post by johnnywick on May 11, 2017 1:14pm

Valeant Pharma To Present At Health Care Conferences

Valeant Pharmaceuticals To Present At Health Care Conferences
17:00:00 05/10/2017

 

LAVAL, Quebec, May 10, 2017 (Canada NewsWire via COMTEX News Network) -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Joseph C. Papa, chairman and chief executive officer, is scheduled to present at the following health care conferences:

-- Bank of America Merrill Lynch 2017 Healthcare Conference on Wednesday, May 17, 2017 at 3:00 p.m. PDT (6:00 p.m. EDT) at the Wynn Las Vegas hotel; -- UBS Global Healthcare Conference to be held on Monday, May 22, 2017 at 9:00 a.m. EDT at the Grand Hyatt New York hotel; and -- Jefferies 2017 Global Healthcare Conference to be held on Wednesday, June 7, 2017 at 8:30 a.m. EDT at the Grand Hyatt New York hotel.

A live webcast and audio archive of the events will be available on Valeant's Investor Relations website and via this URL: https://ir.valeant.com/events-and-presentations

About ValeantValeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant and forward looking statements can be found at www.valeant.com.

Comment by johnnywick on May 11, 2017 1:42pm
This is good news attracting more money down the road
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities